Artículos del autor

solaci

Coronary disease

Is IVUS Guided PCI a Common Technique?

We all know the benefits of ultravascular ultrasound (IVUS) in the development of percutaneous coronary intervention, such...
solaci -
Antiplatelet

An Abbreviated Dual Antiplatelet Regimen Is Also Safe in Patients at High Risk for Bleeding Undergoing Complex Angioplasty

The MASTER DAPT study analyzed the results of an abbreviated (mean 34 days) vs. conventional dual antiplatelet...
solaci -
Antiplatelet

High Risk of Bleeding after PCI: More Evidence for Short DAPT

Dual antiaggregation therapy (DAPT) with ASA and P2Y12 during 6 to 12 months is the indicated strategy...
solaci -
Institutional News

SOLACI-SOCIME 2022 Highlighted Scientific Sessions

INDUSTRY SPONSORED ACTIVITIES Just like every year, the unconditional support of the industry to SOLACI Congress is a...
solaci -
Antiplatelet

Two Safe Stents at Two Years in High Bleeding Risk

There is a consistent number of patients presenting high risk of bleeding. In this context, receiving dual...
solaci -
Institutional News

Thanks everyone for making part of Paraguay SOLACI Sessions 2022!

We have reached the end of SOLACI Sessions 44th edition.  We have enjoyed 2 days of intense scientific...
solaci -
Bifurcations

Coronary Bifurcation Lesions: MRS or PCI? 10-Year Mortality of the SYNTAX Study

Percutaneous treatment of coronary lesions affecting bifurcations has increased in recent decades. Coronary angioplasty (percutaneous coronary intervention,...
solaci -
Institutional News

The XLIV Paraguay Sessions Have Started – Day 1

The day is finally here. The XLIV SOLACI Sessions (15th Southern Cone Region) began in Paraguay, with...
solaci -